跳至主要内容
临床试验/NCT06384703
NCT06384703已完成不适用

The Evaluation of the Relationship Between Coronary Ectasia And Trimethylamine N Oxide

Konya Beyhekim Training and Research Hospital1 个研究点 分布在 1 个国家目标入组 2 人开始时间: 2020年11月3日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
2
试验地点
1
主要终点
death

研究概览

简要总结

Introduction: It is now known that the microbiota is far beyond the microbial communities living in certain parts of our body and functions like a metabolic organ. In addition, the microbiota, through its metabolites, is involved in the pathophysiology or progression of a wide range of diseases, from atherosclerotic diseases to metabolic diseases and even neurological diseases. Among these metabolites, trimethylamine n-oxide metabolite has been shown to be particularly effective on atherosclerotic heart diseases.

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • over 18 years old
  • not having occlusive coronary artery disease
  • having coronary ectasia

排除标准

  • patients with chronic kidney disease,
  • revascularized coronary artery disease,
  • previously documented critical coronary stenosis,
  • acute or chronic inflammatory disease,
  • rheumatologic disease,
  • known active malignant disease,
  • heart failure,
  • moderate-to-severe valvular pathology
  • patients who were on any steroid or immunosuppressive therapy

结局指标

主要结局

death

时间窗: 1 month

Death from any cause within the last month

次要结局

未报告次要终点

研究者

发起方
Konya Beyhekim Training and Research Hospital
申办方类型
Other Gov
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Relationship Between Microbiota and Coronary... | 临床试验